trial · primary record
NXT007
Hemophilia A
| Phase | Phase 3 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 360 |
| Primary completion | 2032-01-29 |
| Primary endpoint | Annualized Bleed Rate (ABR) for Treated Bleeds Over the Main Study Treatment Period |
| Registry ID | NCT07416604 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-04T03:54:26.902Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07416604
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.